Maternal B12 Levels Impact Children's Cardiometabolic Health

This article originally appeared here.
Share this content:
Maternal B<sub>12</sub> Levels Impact Children's Cardiometabolic Health
Maternal B12 Levels Impact Children's Cardiometabolic Health

THURSDAY, Feb. 11, 2016 (HealthDay News) -- Mothers' vitamin B12 levels in early pregnancy may impact children's cardiometabolic risk factors at age 5 years, according to a study published in the February issue of BJOG: An International Journal of Obstetrics & Gynaecology.

G.G. Krikke, from the Academic Medical Centre in Amsterdam, and colleagues identified 1,950 mother-child pairs participating in the Amsterdam Born Children and their Development study for whom information on maternal vitamin B12 or folate status in early gestation and child health at age 5 to 6 years was available.

The researchers found that low maternal folate levels during early pregnancy (median 13 weeks of gestation) were associated with slightly higher body mass index in offspring (decrease per 10 units: β 0.07 kg/m²). There was also an association noted between low maternal vitamin B12 concentrations and higher heart rates (decrease per 100 units: β 0.49 beats/min).

"This study provides further evidence that maternal nutrition in early pregnancy may possibly program cardiometabolic health of the offspring," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths